COMPASS THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
COMPASS THERAPEUTICS, INC. (CMPX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent of -3.10% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch · last filed 2026-03-05
- COMPASS THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2025 was -3.10%.
- COMPASS THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2024 was -5.80%.
- COMPASS THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2022 was 1.40%, a 75.00% increase from fiscal 2021.
- COMPASS THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2021 was 0.80%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month |
|---|---|
| 2025-12-31 | -3.10% 10-K · filed 2026-03-05 |
| 2024-12-31 | -5.80% 10-K · filed 2026-03-05 |
| 2022-12-31 | 1.40% 10-K · filed 2023-03-15 |
| 2021-12-31 | 0.80% 10-K · filed 2023-03-15 |
| 2020-12-31 | 0.00% 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |